Contents:
Document Title
Use of Subcutaneous Proton Pump Inhibitors
Document Date
April 2023
Document Purpose and Intended Audience
This guidance provides information about the use of subcutaneous protonpump inhibitors in palliative care patients
Authors
Dr Laura Dewhirst
Dr Sophie Jones
Dr Alice Martin
Dr Jon Tomas
Consultation Process
Circulated to SPAGG group for comments and approval
Monitoring
This guideline will be audited by members of the SPAGG group at least every 2 years.
Review Date
(must be within three years)
July 2025
Approval Signatures:
SPAGG chair
Dr Jon Tomas
SPAGG secretary
Dr Emma Wooldridge
Date Approved by SPAGG: July 2023
Date submitted to Area Prescribing Committee: N/A
Version History
Version 0.1
Date
April 2023
Summary of change/ process
Guidelines written by Dr Laura Dewhirst, Dr Sophie Jones, Dr Alice Martin and amalgamated into SPAGG format. For circulation to SPAGG.
Disclaimer
These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.
Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.
Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.